Conformational flexibility in the active sites of aspartyl proteinases revealed by a pepstatin fragment binding to penicillopepsin ( Communicated by Joseph S. Fruton, June 21, 1982 ABSTRACT Crystals of the molecular complex between the esterified tripeptide fragment of pepstatin and the aspartyl proteinase penicillopepsin are isomorphous with crystals of native penicillopepsin. The difference electron-density map at 1.8-A resolution, computed by using the amplitude differences and refined phases of reflections from the crystal of native penicillopepsin, unambiguously showed the binding mode of isovaleryl Pepstatin is a naturally occurring inhibitor of aspartyl proteinases (1); it has the amino acid composition isovaleryl (Iva)-ValVal-Sta-Ala-StaOH, in which Sta is the residue of statine [(4S,3S)-4-amino-3-hydroxyl-6-methylheptanoic acid] (2). The interaction ofpepstatin with aspartyl proteases is characterized by small dissociation constants [i.e., 4.6 x 10-11 M with porcine pepsin (3) and 1.5 x 10-10 M with penicillopepsin (unpublished results)]. It Structure I Penicillopepsin is an aspartyl proteinase isolated from the mold Penicillium janthinellum. Its crystal structure (6, 7) has been refined at 1.8-A resolution (8) to a conventional R-factor § of 0.136 for those reflections with I, the intensity of Bragg reflections, equal to or greater than the estimated standard deviation of the intensity measurement derived from counting statistics [I 2 o-(I)]. The aspartyl proteinases are characterized by a long binding cleft that can accommodate 7 or 8 amino acid residues of an oligopeptide substrate in an extended conformation. The two catalytically important aspartyl residues, Asp&jand Asp-213, are centrally located in this binding cleft (Asp32and Asp-215 in the porcine pepsin sequence numbering).
Pepstatin is a naturally occurring inhibitor of aspartyl proteinases (1) ; it has the amino acid composition isovaleryl (Iva)-ValVal-Sta-Ala-StaOH, in which Sta is the residue of statine [(4S,3S)-4-amino-3-hydroxyl-6-methylheptanoic acid] (2) . The interaction ofpepstatin with aspartyl proteases is characterized by small dissociation constants [i.e., 4 .6 x 10-11 M with porcine pepsin (3) and 1.5 x 10-10 M with penicillopepsin (unpublished results)]. It has been suggested that part ofits inhibitory nature is due to the presence ofthe central Sta residue that could mimic the tetrahedral transition state of a good substrate (4, 5) . The chemical formula of pepstatin is: Structure I Penicillopepsin is an aspartyl proteinase isolated from the mold Penicillium janthinellum. Its crystal structure (6, 7) has been refined at 1.8-A resolution (8) to a conventional R-factor § of 0.136 for those reflections with I, the intensity of Bragg reflections, equal to or greater than the estimated standard deviation of the intensity measurement derived from counting statistics [I 2 o-(I)]. The aspartyl proteinases are characterized by a long binding cleft that can accommodate 7 or 8 amino acid residues of an oligopeptide substrate in an extended conformation. The two catalytically important aspartyl residues, Asp&jand Asp-213, are centrally located in this binding cleft (Asp32and Asp-215 in the porcine pepsin sequence numbering).
Fluorescence measurements on the aspartyl proteinases with specific substrates have indicated that conformational mobility of groups in the active site may play an important role in the mechanism of these enzymes (9) .
MATERIALS AND METHODS
The enzyme, penicillopepsin, was prepared, purified, and crystallized as described (6, 7, 10) . Crystals of the native enzyme Least-squares refinement of the initial model deduced at 2.8-A resolution (6, 7) was done with the restrained parameter refinement program of Hendrickson and Konnert (11) . Phases for the 21,962 reflections with I 2 o(I) at 1.8-A resolution were calculated from the final refined model at an R value of 0.136 (8) . This model included 319 solvent molecules in addition to the 2,363 atoms of the native enzyme.
The pepstatin derivative Iva-Val-Val-StaOEt was synthesized by the following procedure. t-Butoxycarbonyl (Boc)-StaOEt (12) was deprotected with 4 M HCl in dioxane and sequentially coupled with Boc-L-valine, Boc-L-valine, and isovaleryl anhydride by using procedures previously described for-the synthesis of pepstatin analogues (13) (17) for two reflections. The falloff of intensity of the diffraction pattern due to radiation damage was corrected by a function of time and 0 (18) . In this way, 30 ,000 reflections were measured from one crystal ofthe complex during a period of31 days. The maximum decay correction required for reflections with sinG/A : 0.264 was 55%, whereas that for the data of low sinG/A was only 15-20%.
The structure factor amplitudes ofthe crystal ofthe molecular complex were scaled to the absolute scale with the program ORESTES (19) . The ratio of the sums of the structure factor amplitudes for the native and complex crystals was 0.941, and no further scaling corrections were made. The agreement index$ between the two appropriately scaled data sets was 0.272.
A difference electron-density map was computed from the coefficients IFomplexl -IFnativel and phases anative, which are the calculated phase angles for the refined structure of penicillopepsin (8) . No attempt to omit the contribution of those waters occupying the immediate vicinity of the active site or neighDefined as -IF IompiexI-IFnativell/l/21IFcomplexI + jFnativell boring substrate binding regions was made in calculating these phases.
The computed map was transferred to the MMS-X interactive graphics (20) at the University of Alberta. The program, M3, designed and developed by C. Broughton, was used for the display of the molecules, electron-density maps, and the animated models of the pepstatin tripeptide for electron-density fitting (21) .
RESULTS AND DISCUSSION
There are only two prominent features in the difference electron-density map. They are readily interpreted as the bound tripeptide inhibitor and a major conformational change in a portion of the enzyme.
Inhibitor Conformation. The difference electron density for the pepstatin fragment Iva-Val-Val-StaOEt bound in the active site is shown in Fig. 2 . With the exception of the terminal methyl groups of Iva-1, the model fits exceptionally well into the electron density. Some distortion of the electron density is to be expected because of the presence of solvent molecules in the native structure used in the phase calculations. Table 1 lists the conformational angles for the residues ofthe pepstatin fragment. These values are the result of the electrondensity fitting and, therefore, are almost certain to change upon refinement of the structure. The 4 values for the backbone of the tripeptide are all close to that expected for an extended polypeptide chain (-120°), but only qf of Val-2 is close to the expected + 1400. Nevertheless, Fig. 2 shows the approximate /3-sheet conformation adopted by the inhibitor with the side chains alternating to the left and to the right of the backbone. In this manner, a polypeptide of 7 or 8 amino acids could be accommodated into the active site of penicillopepsin. This observation agrees well with the kinetic data of Fruton and others, who first indicated an extended binding site for the aspartyl proteinases (23, 24) .
The side-chain confornmational angles, xy, for Val-3 and Sta-4 are well within the most commonly observed values and calculated energetic minima for valyl and leucyl residues, g' and g+t (8, 22) . It is of interest that the enzyme binds the inhibitor with no apparent distortion of this conformation in this most critical portion of the inhibitor molecule. The conformation of Val-2 (g-) is different from that of Val-3 but also within accepted ranges.
Intermolecular Nonbonded Contacts. The conformation of the pepstatin tripeptide fragment and the relative orientation of this inhibitor serve to delineate the binding sites on the penicillopepsin molecule. For convenience we will use the notation of Schechter and Berger (25) to denote the residues on the substrate (in this case, the inhibitor) as P1, P2, and P', P', etc. The overall binding mode of the pepstatin tripeptide inhibitor is shown in Fig. 3 . There are a total of82 nonbonded contacts less than 4.0 A (including hydrogen bonds) that the atoms of the tripeptide inhibitor make with atoms of the enzyme. Fifteen residues of penicillopepsin are engaged in these interactions. By far the largest number of contacts (40 of the total of 82) are made by the P1 Sta residue to 10 residues of penicillopepsin. These residues are Asn-31, Asp-33, Gly-35, Leu-121, Asp-213, Gly-215, Thr-216, and, after the conformational movement of the "flap" (the /3-sheet from Trp-71 to Gly-83), Tyr-75, Asp-77, and Ser-79. An alternative orientation for a P1 lysyl residue having an ion-pair bond between NW of the lysine and the carboxylate ofAsp-38 has been proposed (15, 26) on the basis ofmodelbuilding studies. A hydrogen bond from the nitrogen atom of the P1 residue to the C=O of Gly-215 was proposed previously (26) , also on the basis of model building, and is confirmed by 9 to position the scissile bond appropriately relative to the two aspartyl residues of the active site. There are two key hydrogen bonds involving Val-2, the P3 residue (Fig. 3) . The main-chain NH of Val-2 donates a proton The ethyl group.of the ester occupies a hydrophobic pocket that-has been identified as a probable S' binding site on penicillopepsin (26 (8, 14) . This region is extensively and in-Proc. Natl. Acad. Sci. USA 79 (1982)   FIG. 3 . The active-site region (in stereo) of native penicillopepsin at 1.8-A resolution (8) . Superimposed is the molecular model of the pepstatin fragment as deduced from the difference electron-density map (Fig. 2) . The flap is shown in the position determined for the native enzyme crystals.
tricately hydrogen-bonded (see Fig. 2 ) and is the least mobile (or flexible) region of the molecule, as judged by the relatively low isotropic thermal B factors (8) . However, conformational flexibility of some segment of the molecule close to the active site or binding region is indicated by many kinetic and substrate binding studies (9) . It is not yet established that conformational flexibility is mandatory for the sequence of events that involve the covalency changes ofpeptide bond hydrolysis, and the present data would indicate that this is not necessary. However, mobility of the flap was suggested as one of the prerequisite steps to accommodate substrates in the extended binding clefts of the aspartyl proteases (14) . The present study confirms this proposal and extends the interpretation of the possible role of this flap region in the hydrolytic and transpeptidation events. This segment ofpenicillopepsin undergoes a substantial change in conformation and its concerted movement is depicted in Fig.  4 . It can be seen that residues from Trp-71 to Gly-83 lie in a continuous region ofnegative electron density on the difference map. This indicates that these residues do not have the same relative position in the complex as they do in the crystals of native, uncomplexed penicillopepsin. Indeed, lying adjacent to the negative density contour surface is a continuous stretch The details of this very simple model of the movement will undoubtedly change upon refinement, but it accounts well for the appearance of the difference electron-density map (Fig. 4) .
The far-reaching implications of this conformational change are numerous. The new position ofthe flap requires movement of atoms in the neighborhood of Gly-76 and Asp-77 by =2.2 A. The side chain of Asp-77 and portions of the main chain in this region are brought into close proximity of the pepstatin inhibitor, thus permitting the formation of hydrogen bonds between atoms of the flap and the inhibitor. As these hydrogen bonds are exclusively to the polypeptide chain of the pepstatin tripeptide, side-chain specificity is not part of the interaction, and similar contacts and hydrogen bonds could also form with the backbone of a good substrate. These hydrogen-bonding interactions clearly help to position the scissile bond in the proper orientation relative to the catalytic apparatus of the aspartyl proteinases.
The movement of the flap eliminates the possible role of proton donor for the p-hydroxyl group of Tyr-75 (7, 14, 15, 26 ). An earlier study (7) that involved binding 1,2-epoxy-3-p-nitrophenoxypropane to penicillopepsin elicited a movement of the side chain of Tyr-75 towards the active site, suggesting that Tyr-75 played a role of proton donor to the leaving group nitrogen in the catalytic mechanism ofaspartyl proteinases (15, 26) . However, the present study shows that if the observed conformational change of the flap also takes place when a good substrate binds to penicillopepsin, then the side chain of Tyr-75 can only enhance the specific binding interactions to the P1 side chain, which often exhibits an aromatic preference (24, 27) .
Finally, conformational changes that involve the flap region ofthe molecule can begin to explain the acyl and amino transfers (24, 28, 29) that occur in transpeptidation reactions. Covalent intermediates are not likely in the aspartyl proteinase mechanism (7, 14, 15) . Residues NH2-terminal to the scissile bond (P1 and P2) would be kept preferentially in place after hydrolysis by the new interactions made with residues of the flap after its conformational change. The large differences in yields ofamino transpeptidations between penicillopepsin (low yield) and porcine pepsin can possibly be accounted for by a four-residue insertion in pepsin after Asn-290 relative to penicillopepsin. These residues, Asp-Val-Pro-Thr, could adopt a conformation resembling a flap that could interact preferentially with residues P', P', and P3 ofa substrate, thus providing an explanation for the efficiency of the amino-transfer reactions of pepsin. However, the conformational changes observed may not be sufficient to account for the failure of the intermediates in the transpeptidation reactions to exchange their acyl or amino moieties with the corresponding free amino acids in the reaction mixture (30 
